14 th Annual 340B Coalition Conference On Improving Access to Pharmaceutical Care and Ensuring Compliance with Federal and State Laws The Credit and Re-bill.

Slides:



Advertisements
Similar presentations
Issues and Compliance Strategies Related to Government Pricing Joseph W. Metro.
Advertisements

Health Insurance Exchanges under the Affordable Care Act Deborah Chollet, Ph.D. Senior Fellow.
THE URBAN INSTITUTE Genevieve Kenney 2009 ACAP Medicaid Managed Care Policy Summit Hotel Monaco – Washington, DC July 15, 2009 Health Reform for Children:
AASHTO/FHWA Right of Way and Utilities Subcommittee Conference Austin, Texas May 16, 2005 “Consultant Performance Oversight” Gus Cannon, SR/WA.
Investigating Age Discrimination Complaints 16 th Annual National Equal Opportunity Conference US Department of Labor Washington, DC August 25, 2005.
LOCAL REVOLVING LOAN FUND (RLF). Page 2 Local Revolving Loan Funds Indications that HUD and GAO will heavily monitor and audit the RLF activities HUD.
INTEGRITY ● ACCESS ● VALUE 1 The 340B Drug Pricing Program: The Basics Paul Shank Health & Human Services Consultant, Health Resources and Services Administration.
Optimizing The 340B Program Promoting Integrity, Access, & Value To deliver clinically and cost-effective pharmacy services This educational product created.
1099 new york avenue, nw | suite 530 | washington dc |
1 1 © 2013 SUNRx and MedImpact, Inc. All Rights Reserved. Confidential, proprietary and possible Trade Secret of SUNRx and MedImpact (See Slide #1) The.
Unified Carrier Registration (UCR) Update August 24, 2006.
The Patient Protection & Affordable Care Act (ACA) implements broad, historic changes to U.S. health care Expanded access to health insurance and care.
New European Regulations covering Investable Indices Two new sets of European Regulations covering Benchmarks (Indices) where there are investment products.
Clarity, consent and coverage for research-related injuries 6 th Annual Columbia University IRB Conference Boston, MA Patrick Taylor Children’s Hospital.
Building a Special Education Infrastructure Through a Joint Power Authority.
Optimizing The 340B Program Promoting Integrity, Access, & Value To deliver clinically and cost-effective pharmacy services This educational product created.
Britten Pund, Senior Manager, Health Care Access Emily McCloskey, Manager, Policy and Legislative Affairs The Ryan White Program and 340B Pharmacies.
340b Program Background. Proprietary and Confidential. Do not distribute. General Overview What is the 340b program Recent legislative changes and the.
The Unexpected Impact of Information-Sharing on US Pharmaceutical Supply Chains Leroy B. Schwarz and Hui Zhao Krannert School of Management.
1 HOBBS STRAUS DEAN & WALKER, LLP WASHINGTON, DC | PORTLAND, OR | OKLAHOMA CITY, OK | SACRAMENTO, CA Tribal Authority to Collect and Use Third-Party Revenues.
© Wipfli LLP 2015 HFMA Annual Update January 30, 2015.
Clarity, consent and coverage for research-related injuries 6 th Annual Columbia University IRB Conference Boston, MA Patrick Taylor Children’s Hospital.
Department of Health Care Finance Primary Care Enhanced Rates Presentation by: Claudia Schlosberg. JD Director, Health Care Policy and Research Administration.
With respect to travel, meal and hospitality expenses:  Provide an overview of Bill 122  Discuss the importance of compliance.
Supply Chains for Healthcare Products: Are They ‘Wacky’ or Not? Leroy B. Schwarz Krannert School of Management.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
March Sliding Fee Scales, Patients Cap on Charges Eli Camhi, MSSW – Tom Hickey -
Challenges and Opportunities Under The 340B Program Safety Net Hospitals for Pharmaceutical Access Ted Slafsky, Executive Director May 10, 2010, 4:00-5:00.
Legal Division Commercial and Property Law Unit Services Presentation by Regina Ewing Senior Lawyer, Commercial and Property Law Unit Legal Division.
Working Together To Improve Access To Care Presentation to Center for Business Intelligence Patient Assistance Programs Conference March 11, 2003 Alexandria,
340B Drug Discount Program 2013 May 16, 2013 May 16,
340B: An Overview.
The 340B Program: An Overview NGA/NCSL Web-assisted Audioconference August 5, 2005 Diane P. Goyette, RPh, JD U.S. Department of Health and Human Services.
Marianne Klaas, RN, MN, CHSP Swedish Medical Center Administrative Director Accreditation, Safety, Injury Management, and Clinical Patient Relations Contract.
AMA’s National Managed Care Contract and Database Wes Cleveland, JD American Medical Association
An Integrated Healthcare System’s Approach to ACOs Chuck Baumgart, M.D., Chief Medical Officer Presbyterian Health Plan David Arredondo, M.D., Executive.
Health Care Reform and its Impact on Michigan Janet Olszewski, Director Michigan Department of Community Health Senate Health Policy Committee May 5, 2010.
Government Finances Chapter 25. The Federal Government Section 1.
Responding to Enforcement Initiatives: Designing the Successor(s) to the Medicaid Rebate Program The Fourth Annual Pharmaceutical Regulatory and Compliance.
Veterans Access, Choice and Accountability Act of 2014 (VACAA) The Choice Program, the Choice Card, and the Future.
Commonwealth of Massachusetts Executive Office of Health and Human Services Implementing the Affordable Care Act in Massachusetts 2012 Legislative Changes.
National Pharma Audioconference: Pharmaceutical Drug Pricing and Reporting Issues July 28, 2005 Government Price Reporting: Common Problem Areas in a Complex.
Slide 1 Drug Pricing Considerations Medicare Prescription Drug, Improvement, and Modernization Act of 2003 ___________ Copyright 2005 Arnold & Porter July.
PwC Pharmaceutical Drug Pricing and Reporting Issues A Brief Overview of Government Drug Price Reporting Requirements July 28, 2005 National Parma Audioconference.
© Huron Consulting Services LLC. All rights reserved. Practical Case Study: A Compliance Professional’s Playbook for Conducting a Government Price Reporting.
© Hogan & Hartson LLP. All rights reserved. Alice Valder Curran, Partner Tuesday, October 17, 2006 Private Prices, Public Markets: The Evolution of Price.
FleetBoston Financial HIPAA Privacy Compliance Agnes Bundy Scanlan Managing Director and Chief Privacy Officer FleetBoston Financial.
GOVERNMENT CONTRACTS: FALSE CLAIMS AND COMPLIANCE Robert M. Jenkins III Mayer, Brown & Platt Presentation To The Fifth Annual National Congress on Health.
Copyright © 2013 by The National Restaurant Association Educational Foundation. Published by Pearson. All rights reserved. HOSPITALITY HUMAN RESOURCES.
The Peculiar Economics of Federal Energy Management Michael E. Canes USAEE Annual Conference October 26, 2015.
Insurance from a Corporate Perspective Chartered Institute of Management Accountants 28 July 2015.
Medicaid County Billing Florida Association of Counties Annual Conference June 23, 2011.
340B PRICING AND PROCUREMENT ELIGIBILITY, ENROLLMENT, AND REQUIREMENTS Virtual Health Center’s eHealthUniversity Dr. Erica C. Watkins, PharmD, RPh August.
Managed Care Pharmacy Financials January 15, 2015.
Office of Pharmacy Affairs 340B Drug Pricing Program Bradford R. Lang JD, MPH Public Health Analyst US Dept. of Health and Human Services Health Resources.
340B PROGRAM AND BEST PRICE LAW HIGPA 2003 National Pharmacy Forum February 4, 2003 Presentation By Ted Slafsky Director Public Hospital Pharmacy Coalition.
© South-Western Educational Publishing Chapter 23 Buying and Caring for a Vehicle  Buying a Vehicle  Maintaining Your Vehicle.
By Bill von Oehsen President and General Counsel Safety Net Hospitals for Pharmaceutical Access 12 th Annual 340B Coalition Conference July 16, 2008 Washington,
340B Introduction Session by Bill von Oehsen President and General Counsel Safety Net Hospitals for Pharmaceutical Access 340B Workshop & Networking Luncheon.
Chapter 5 Healthcare Reform. Objectives After studying this chapter the student should be able to: Describe the expansion of healthcare insurance under.
Analyzing the Impact of the DRA on the 340B Program by Stuart Yael Gordon Director of Legal and Regulatory Affairs Safety Net Hospitals for Pharmaceutical.
Sub-recipient Monitoring and Contractor Determination
Hemophilia Alliance Fall Meeting 2017
Multifamily Partnership Opportunities Annual Conference of the
Pharmaceutical Pricing and Contracting: An Overview March 2006
Increasing Capacity to Provide Immunization Services
A Short History of Pricing Related Fraud and Abuse Issues 8th Annual Pharmaceutical Regulatory Compliance Congress and Best Practices Forum Washington,
Brussels, June 6, 2007 Paul E. Kalb, M.D., J.D.
Expensive commercial practices
“Netting” Prices Pharmaceutical Compliance Congress November 15, 2004
Presentation transcript:

14 th Annual 340B Coalition Conference On Improving Access to Pharmaceutical Care and Ensuring Compliance with Federal and State Laws The Credit and Re-bill Process The Manufacturer Perspective Omni Shoreham Hotel, Washington D.C. Monday, July 19 th – Wednesday, January 21 st

Manufacturer Perspective Manufacturers have a heavy operational burden – Sign blanket agreement, applies to all covered products – Calculate and publish the PHS Price – Maintain accurate PHS Contract Eligibility – Process and pay the chargeback Program is very visible and high risk from compliance perspective The manufacturer has limited view to the purchasing entity – It is not the manufacturer’s accountability to ensure the entity is compliant – Manufacturer’s have limited visibility to the wholesale and the entity, rely primarily on chargeback data, which is after the purchase – Lack of guidance on what action/recourse is available 2

Various Drivers to the Process Important to understand what is driving the process – Routine/administrative Normally within a certain time period – Multi-year look-backs Applying retroactive pricing – Retroactive eligibility i.e., Children’s hospital eligibility 3

Challenges/Issues Compliance and Statutory Pricing – Driving restatements in Medicaid and PHS, as Commercial GPO purchases become exempt Government Purchases – Limited view as to whether the purchase is a legitimate out-patient PHS purchase – Manufacturers are expected to do appropriate due diligence to only honor chargebacks for what they deem to be eligible entities and purchases Accounting Challenges – Reconciling historical chargebacks – Impact on GPO Administrative Fees 4

Need to establish appropriate controls and processes Where there is a legitimate PHS purchase that needs to be “reclassified” – Was the driver a result of the product being shifted from GPO inventory to PHS Clinic inventory to fill the need? – Can the purchase to refill inventory now be through a PHS contract? Was it a case where an entity determined that they could have purchased under the PHS contract and did not? 5

Putting process and controls in place Seek an efficient way to manage the routine, operational aspect of legitimate “rebills,” while also having polices and controls in place for multi-year lookbacks 6